In the United States, EXOMIND is intended for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Any use outside of that indication is considered off-label and is offered on a cash-pay basis, based on provider judgment and emerging research. Off-label uses are not FDA-cleared indications. Individual results vary. TMS is not a cure, and no outcome is guaranteed. This page is patient education, not medical advice.
Welcoming patients from Inglewood, Hawthorne, Ladera Heights, Westchester, El Segundo, Culver City, Gardena, South Los Angeles, View Park-Windsor Hills, Leimert Park, Marina del Rey.
© 2026 Inglewood TMS Center. All rights reserved.3217 W Imperial Hwy, Inglewood, CA 90303
